| Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College London, 2020 | 5032 | 2020 |
| Estimates of the severity of coronavirus disease 2019: a model-based analysis R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ... The Lancet infectious diseases 20 (6), 669-677, 2020 | 4429 | 2020 |
| Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Nature 584 (7820), 257-261, 2020 | 4144* | 2020 |
| Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ E Lavezzo, E Franchin, C Ciavarella, G Cuomo-Dannenburg, L Barzon, ... Nature 584 (7821), 425-429, 2020 | 1037 | 2020 |
| The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ... Science 369 (6502), 413-422, 2020 | 957 | 2020 |
| Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ... The Lancet global health 8 (9), e1132-e1141, 2020 | 859 | 2020 |
| The global impact of COVID-19 and strategies for mitigation and suppression PGT Walker, C Whittaker, O Watson, M Baguelin, KEC Ainslie, S Bhatia, ... Imperial College London 26, 1-19, 2020 | 703 | 2020 |
| Reduction in mobility and COVID-19 transmission P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ... Nature communications 12 (1), 1-9, 2021 | 591 | 2021 |
| Estimates of the severity of COVID-19 disease R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ... MedRxiv, 2020.03. 09.20033357, 2020 | 426 | 2020 |
| Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College COVID-19 Response Team 20 (10.25561), 77482, 2020 | 390 | 2020 |
| Report 3: transmissibility of 2019-nCoV N Imai, A Cori, I Dorigatti, M Baguelin, CA Donnelly, S Riley, ... Imperial College London 625, 1-6, 2020 | 375 | 2020 |
| Age groups that sustain resurging COVID-19 epidemics in the United States M Monod, A Blenkinsop, X Xi, D Hebert, S Bershan, S Tietze, M Baguelin, ... Science 371 (6536), eabe8372, 2021 | 344 | 2021 |
| Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study M Baguelin, S Flasche, A Camacho, N Demiris, E Miller, WJ Edmunds PLoS medicine 10 (10), e1001527, 2013 | 322 | 2013 |
| Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ... The Lancet Infectious Diseases 20 (12), 1381-1389, 2020 | 213 | 2020 |
| Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation M Baguelin, AJ Van Hoek, M Jit, S Flasche, PJ White, WJ Edmunds Vaccine 28 (12), 2370-2384, 2010 | 212 | 2010 |
| Response to COVID-19 in South Korea and implications for lifting stringent interventions A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ... BMC medicine 18, 1-12, 2020 | 204 | 2020 |
| The potential public health consequences of COVID-19 on malaria in Africa E Sherrard-Smith, AB Hogan, A Hamlet, OJ Watson, C Whittaker, ... Nature medicine 26 (9), 1411-1416, 2020 | 188 | 2020 |
| State-level tracking of COVID-19 in the United States HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ... Nature communications 11 (1), 6189, 2020 | 180 | 2020 |
| Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology K Dee, DM Goldfarb, J Haney, JAR Amat, V Herder, M Stewart, ... Journal of Infectious Diseases 224 (1), 31-38, 2021 | 163* | 2021 |
| Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study R Sonabend, LK Whittles, N Imai, PN Perez-Guzman, ES Knock, ... The Lancet 398 (10313), 1825-1835, 2021 | 162 | 2021 |
Neil FergusonImperial CollegeVerified email at imperial.ac.uk
